ArticleMolecular genetics and genomics : MGG2026
New variant in KITLG shapes the pathogenesis of familial progressive hyper- and hypo-pigmentation.
Article in Molecular genetics and genomics : MGG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Role of Phytocompounds and the Physiological Response of the Skin in Common Dermatological Conditions: A Narrative Review and Bibliometric Analysis of Trends.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Familial progressive hyper- and hypo-pigmentation (FPHH) is a pigmentary disorder characterized by a mixture of hypo- and hyper-pigmentation lesions, brown spots, and hypo-pigmentation gray leaf spots. This disease had previously been reported to be associated with the KITLG gene. In this study, whole exome sequencing was performed to identify the gene mutation in two patients suspected with FPHH. Functional changes were explored at a cellular level with the help of adenine base editors, and the differentially expressed genes in the melanin pathway were detected through RNA-sequencing. Mutations were identified in two patients at exon 4 of KITLG (NM_000899.4): [c.329 A > T] and [c.329 A > G]. The c.329 A > G is a de novo mutation. The two variations were located in a conservative region and were predicted to be likely pathogenic mutations. For de novo c.329 A > G mutation, results showed that the mutation broadly affected the transcription and translation of genes responsible for melanin synthesis, especially the melanin gene MITF. These results indicated that the conservative locus c.329 A had an important function to KITLG, mutations [c.329 A > T] and [c.329 A > G] in KITLG could result FPHH. Based on the functional tests, c.329 A > G could be pathogenic mutant. This study has an important clinical significance, and it would extend the mutation spectrum of KITLG gene. It would improve the disease knowledge base and offer a reliable reference for the clinical diagnosis and prevention of FPHH.
Indexed as
Identifiers
41779177What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.